Currently browsing tag


When marketing becomes strategy (or a key strategic pillar) – the case of Cialis’ challenge of Viagra’s market

The strategic question for Lilly Icos was whether it could influence how physicians perceived the importance of the criteria (longer lasting effects). The positioning was hotly debated prior to launch: Should the company centre its marketing strategy on Cialis’s lack of side effects, given that safety was already one of …